Interest Expense in USD of Eiger BioPharmaceuticals, Inc. from 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Interest Expense history and change rate from 2012 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Interest Expense for the quarter ending 31 Dec 2023 was $1.43M, a 16.9% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. Interest Expense for the twelve months ending 31 Dec 2023 was $5.47M, a 32.3% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2023 was $5.47M, a 32.3% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2022 was $4.13M, a 16.1% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2021 was $3.56M, a 0.97% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $5.47M $1.43M +$206K +16.9% 01 Oct 2023 31 Dec 2023 10-K 08 Apr 2024
Q3 2023 $5.26M $1.41M +$320K +29.3% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $4.94M $1.34M +$409K +43.8% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $4.53M $1.29M +$399K +45% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $4.13M $1.22M +$320K +35.6% 01 Oct 2022 31 Dec 2022 10-K 08 Apr 2024
Q3 2022 $3.81M $1.09M +$198K +22.1% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $3.61M $934K +$54K +6.14% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $3.56M $886K +$1K +0.11% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $3.56M $900K -$13K -1.42% 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $3.57M $894K -$12K -1.33% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $3.58M $880K -$11K -1.24% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $3.6M $885K +$1K +0.11% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $3.59M $913K +$25K +2.82% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2023
Q3 2020 $3.57M $906K +$22K +2.49% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $3.55M $891K +$22K +2.53% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $3.53M $884K +$119K +15.6% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $3.41M $888K +$133K +17.6% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2022
Q3 2019 $3.27M $884K +$203K +29.8% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $3.07M $869K +$374K +75.6% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $2.7M $765K +$367K +92.2% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $2.33M $755K +$360K +91.1% 01 Oct 2018 31 Dec 2018 10-K 09 Mar 2021
Q3 2018 $1.97M $681K +$293K +75.5% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 $1.68M $495K +$117K +31% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $1.56M $398K +$35K +9.64% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $1.52M $395K 01 Oct 2017 31 Dec 2017 10-K 13 Mar 2020
Q3 2017 $388K 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $378K 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 $363K -$322K -47% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q1 2016 $525K $685K +$175K +34.3% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 $350K -$1.95M 01 Oct 2015 31 Dec 2015 10-K 09 Mar 2018
Q3 2015 $1.35M +$1.08M +397% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $445K 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2015
Q1 2015 $510K +$451K +764% 01 Jan 2015 31 Mar 2015 10-Q 15 May 2015
Q3 2014 $271K 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q1 2014 $59K 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015

Eiger BioPharmaceuticals, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.47M +$1.33M +32.3% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2024
2022 $4.13M +$573K +16.1% 01 Jan 2022 31 Dec 2022 10-K 08 Apr 2024
2021 $3.56M -$35K -0.97% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 $3.59M +$188K +5.52% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023
2019 $3.41M +$1.08M +46.2% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022
2018 $2.33M +$805K +52.8% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021
2017 $1.52M +$834K +121% 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2020
2016 $690K +$340K +97.1% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 $350K -$391K -52.8% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018
2014 $741K +$682K +1156% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 $59K -$49K -45.4% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016
2012 $108K 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.